The U.S. FDA approved Basaglar (insulin glargine injection), the newest diabetes treatment from the Lilly-Boehringer Ingelheim diabetes…
Category: Products & Tech
Another nice thing about the OmniPod is that the process to change the infusion set is simpler. This means that my daughters can do it themselves more easily and at a younger age. It still hurts, though.
A U.S. FDA safety review has resulted in adding warnings to the labels of a specific class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors (such as Invokana, Farxiga and Jardiance) about the risks of too much acid in the blood and of serious urinary tract infections. Both conditions can result in hospitalization.
Dex Share meant that—if our entire family was home and our son went high or low—two cell phones and the Dex receiver would sound their alarms, sparking red alerts from every room. If that was contributing to my anxiety, what was it doing to my seven-year-old son?
The first improvement over Lantus, according to Hobbs, is simply the length of time the insulin lasts. While Lantus lasts up to 24 hours per dose “with no pronounced peak,” Tresiba lasts considerably longer.
Medtronic has announced that it will no longer sell its CGM Sof-sensor as of Dec. 1, 2015. Medtronic is offering no out of pocket cost conversion programs to their latest insulin pump and CGM technology, the MiniMed 530G with Enlite.
In the midst of all this fear and anxiety brought on by excess knowledge about my blood sugars, I began to speculate that a dystopian end-point for all this wearable technology and increased self-awareness could be a society of terrified hypochondriacs.
More than two years after dealing Novo Nordisk a surprising setback, the U.S. Food and Drug Administration has approved Tresiba (insulin degludec…
I hated the way my pump interfered with my outfits. I hated the middle of the night beeping. And I really hated changing the reservoir. Yet, since I’d been pumping since I was eight years old, by the time I was in my freshman year of college, being on a pump was all I knew.
Several months ago the FDA warned that SGLT2 inhibitors like Invokana may cause diabetic ketoacidosis, a condition that occurs when there is…